investing-statsSEC Form 4 insider transactions

ARTV · Artiva Biotherapeutics, Inc.

← all insiders

Biological Products, (No Diagnostic Substances) · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades22
Distinct insiders5
Bought$10.03M
Sold$1.02M
Net flow$9.01M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for ARTV
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-09-08RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorA buy13,750 13,750 Common Stock13,750filing
2026-09-08Stoppel LauraDirectorA buy13,750 13,750 Common Stock13,750filing
2026-09-08Sorg Elaine K.DirectorA buy13,750 13,750 Common Stock13,750filing
2026-09-08HOUGEN ELIZABETH LDirectorA buy13,750 13,750 Common Stock13,750filing
2026-09-08DANIELS BRIANDirectorA buy13,750 13,750 Common Stock13,750filing
2026-09-08Baker Daniel G.DirectorA buy13,750 13,750 Common Stock13,750filing
2026-09-08MOORE ALISONDirectorA buy13,750 13,750 Common Stock13,750filing
2026-09-04Horan ChristopherOfficer (Chief Tech Operations Officer)S sell10,3660$11.16$115.6K283,084−4%−0.02% (now 0.58%)filing
2026-09-04Bush JenniferOfficer (COO, CLO, Compliance Officer)S sell8,3910$11.16$93.6K329,529−2%−0.02% (now 0.67%)filing
2026-09-04Banerjee SubhashisOfficer (Chief Medical Officer)S sell1,1000$11.16$12.3K140,947−0.8%−<0.01% (now 0.29%)filing
2026-09-04Aslan FredDirector, Officer (Chief Executive Officer)S sell61,8880$11.16$690.4K1,473,194−4%−0.13% (now 3.0%)filing
2026-08-31Banerjee SubhashisOfficer (Chief Medical Officer)M sell10b5-15,306 5,306 Common Stock74,265filing
2026-08-31Banerjee SubhashisOfficer (Chief Medical Officer)S sell10b5-18,2220$12.01$98.7K142,047−5%−0.02% (now 0.29%)filing
2026-08-31Banerjee SubhashisOfficer (Chief Medical Officer)M buy10b5-15,3060$1.92$10.2K150,269+4%+0.01% (now 0.31%)filing
2026-08-19Banerjee SubhashisOfficer (Chief Medical Officer)M sell10b5-1429 429 Common Stock79,571filing
2026-08-19Banerjee SubhashisOfficer (Chief Medical Officer)S sell10b5-14290$12.00$5.1K144,963−0.3%−<0.01% (now 0.30%)filing
2026-08-19Banerjee SubhashisOfficer (Chief Medical Officer)M buy10b5-14290$1.92$824145,392+0.3%+<0.01% (now 0.30%)filing
2026-07-31RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy24,9440$9.93$247.7K17,329,570+0.1%+0.05% (now 35%)filing
2026-07-31RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy20,8240$9.99$208.0K17,304,626+0.1%+0.04% (now 35%)filing
2026-07-28RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy41,3190$9.99$412.8K17,283,802+0.2%+0.08% (now 35%)filing
2026-07-23RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy59,8800$9.96$596.4K17,242,483+0.3%+0.12% (now 35%)filing
2026-07-23RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy84,1240$9.93$835.4K17,182,603+0.5%+0.17% (now 35%)filing
2026-07-23RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy120,5820$9.55$1.15M17,098,479+0.7%+0.25% (now 35%)filing
2026-07-23RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy6,5220$8.94$58.3K16,817,543+<0.1%+0.01% (now 34%)filing
2026-07-20RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy7,8820$8.95$70.5K16,977,927+<0.1%+0.02% (now 35%)filing
2026-07-20RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy152,4720$8.93$1.36M16,970,045+0.9%+0.31% (now 35%)filing
2026-07-14RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy6,5520$8.94$58.6K16,817,573+<0.1%+0.01% (now 34%)filing
2026-07-14RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy15,1020$8.97$135.5K16,811,021+<0.1%+0.03% (now 34%)filing
2026-06-29RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy1,8760$8.98$16.8K16,795,919+<0.1%+<0.01% (now 34%)filing
2026-06-29RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy31,0000$8.88$275.3K16,794,043+0.2%+0.06% (now 34%)filing
2026-06-16RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy124,8930$8.89$1.11M16,763,043+0.8%+0.26% (now 34%)filing
2026-06-16RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy15,4140$8.99$138.6K16,638,150+<0.1%+0.03% (now 34%)filing
2026-06-16RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy391,0190$8.57$3.35M16,622,736+2%+0.80% (now 34%)filing
2026-06-11RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy548,5800$7.91$4.34M16,231,717+3%+1.1% (now 33%)filing
2026-06-11RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy1030$7.00$72115,683,137+<0.1%+<0.01% (now 32%)filing
2026-06-11RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy479,0390$6.91$3.31M15,683,034+3%+0.98% (now 32%)filing
2026-05-28GC Corp. +1 more10% ownerP buy347,2220$11.52$4.00M1,607,734+28%+0.71% (now 3.3%)filing
2026-05-28GC Corp. +1 more10% ownerP buy1,085,0690$11.52$12.50M4,391,969+33%+2.2% (now 9.0%)filing
2026-05-19Raymon HeatherOfficer (SVP, Research and Development)S sell3,0950$9.01$27.9K148,228−2%−<0.01% (now 0.30%)filing
2026-05-19Horan ChristopherOfficer (Chief Tech Operations Officer)S sell7,0020$9.01$63.1K293,450−2%−0.01% (now 0.60%)filing
2026-05-19Bush JenniferOfficer (COO, CLO, Compliance Officer)S sell8,7900$9.01$79.2K337,920−3%−0.02% (now 0.69%)filing
2026-05-19Banerjee SubhashisOfficer (Chief Medical Officer)S sell7,0370$9.01$63.4K144,963−5%−0.01% (now 0.30%)filing
2026-05-19Aslan FredDirector, Officer (Chief Executive Officer)S sell27,1160$9.01$244.3K1,535,082−2%−0.06% (now 3.1%)filing
2026-05-19Miralles Gines DiegoOfficer (President & Head of R&D)A buy232,500 232,500 Common Stock232,500filing
2026-05-19Miralles Gines DiegoOfficer (President & Head of R&D)A buy77,500077,500new+0.16% (now 0.16%)filing
2026-05-13RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy2,170,138 2,170,138 Common Stock$11.52$25.00M2,170,138filing
2026-05-13RA CAPITAL MANAGEMENT, L.P. +5 moreDirector, 10% owner, DirectorP buy6,510,4160$11.52$75.00M15,203,995+75%+13% (now 31%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.